Bahrain vs Sri Lanka: Share of E. coli infections resistant to cephalosporins
Bahrain
63.0%
in 2022
Sri Lanka
58.8%
in 2022
Bahrain rank
9th
Sri Lanka rank
12th
Share of E. coli infections resistant to cephalosporins over time
- Bahrain
- Sri Lanka
How they compare
Bahrain currently reports 63.0% against 58.8% in Sri Lanka, a difference of 4.2%.
That makes Bahrain's figure about 1.1 times Sri Lanka's.
The two have swapped places 1 time across 5 shared years of data; in 2018 it was Sri Lanka ahead.
Bahrain ranks 9th and Sri Lanka ranks 12th of 46 countries.
Across the 2 decades both report, Bahrain averaged higher in 1 and Sri Lanka in 1.
Head to head by decade
| Decade | Bahrain | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.5% | 65.3% | 16.8% | Sri Lanka |
| 2020s | 59.9% | 59.2% | 0.7% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Bahrain or Sri Lanka?
- Bahrain, at 63.0% against 58.8% in Sri Lanka as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Bahrain and Sri Lanka?
- 4.2%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Sri Lanka?
- 5 years are reported by both, from 2018 to 2022.
- How do Bahrain and Sri Lanka rank globally for share of e. coli infections resistant to cephalosporins?
- Bahrain ranks 9th and Sri Lanka ranks 12th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).